Published in J Infect Dis on April 03, 2012
Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis. J Infect Dis (2012) 1.15
Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines. Infect Immun (2014) 0.97
New Insights into IDO Biology in Bacterial and Viral Infections. Front Immunol (2014) 0.92
How to make it in the urinary tract: a tutorial by Escherichia coli. PLoS Pathog (2012) 0.85
Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. Infect Immun (2012) 0.85
Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients. PLoS One (2014) 0.83
Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36. PLoS One (2014) 0.80
Quantitative assessment of human neutrophil migration across a cultured bladder epithelium. J Vis Exp (2013) 0.80
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80
Adaptive immunity to fungi. Cold Spring Harb Perspect Med (2014) 0.80
Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens (2016) 0.79
Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med (2016) 0.77
A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol (2016) 0.77
Neutrophil recruitment and activation in decidua with intra-amniotic IL-1beta in the preterm rhesus macaque. Biol Reprod (2014) 0.77
Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli. Infect Immun (2016) 0.76
Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activation. Oncotarget (2016) 0.75
Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential. J Leukoc Biol (2014) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
The complete genome sequence of Escherichia coli K-12. Science (1997) 84.27
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Intracellular bacterial biofilm-like pods in urinary tract infections. Science (2003) 7.10
Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A (1984) 5.96
Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A (2006) 5.13
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J (2000) 5.03
Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood (1998) 5.02
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A (2004) 4.12
Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med (2008) 3.40
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A (2006) 3.36
Partial purification and characterization of an escherichia coli toxic factor that induces morphological cell alterations. Infect Immun (1983) 2.69
Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun (1986) 2.65
1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch Biochem Biophys (1991) 2.24
A murine model of urinary tract infection. Nat Protoc (2009) 2.15
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int Immunol (2004) 2.13
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun (2006) 2.11
Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect (2010) 1.95
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect Immun (2001) 1.66
Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun (2006) 1.56
Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun (2005) 1.55
Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur J Immunol (2001) 1.51
Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine (2000) 1.41
Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect (2008) 1.39
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun (2003) 1.38
Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. J Biol Chem (1990) 1.36
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol (2008) 1.22
Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. J Infect Dis (2011) 1.18
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun (2005) 1.15
Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxygenase cDNA. Biochem Biophys Res Commun (1990) 1.14
OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun (2009) 1.08
Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect (2011) 1.07
A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol (2005) 1.04
Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection. J Immunol (2009) 1.02
The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Clin Exp Immunol (2011) 0.92
Wounding the immune system with its own blade: HIV-induced tryptophan catabolism and pathogenesis. Curr Med Chem (2011) 0.89
Morphological plasticity as a bacterial survival strategy. Nat Rev Microbiol (2008) 2.28
Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis (2009) 2.24
Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A (2006) 2.15
Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect (2010) 1.95
Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J Urol (2004) 1.82
contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis (2009) 1.74
Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun (2006) 1.56
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun (2003) 1.38
Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J Bacteriol (2005) 1.35
A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. Biochemistry (2011) 1.33
A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis (2013) 1.33
Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr Opin Microbiol (2005) 1.13
OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun (2009) 1.08
Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect (2011) 1.07
The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J (2011) 1.03
Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics. Chem Commun (Camb) (2009) 1.02
Vancomycin trough concentrations in overweight or obese pediatric patients. Pharmacotherapy (2013) 0.93
Synthetic polymer nanoparticles conjugated with FimH(A) from E. coli pili to emulate the bacterial mode of epithelial internalization. J Am Chem Soc (2012) 0.89
YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration. Infect Immun (2012) 0.88
Components of SurA required for outer membrane biogenesis in uropathogenic Escherichia coli. PLoS One (2008) 0.87
Salmonella ovarian abscess in an adolescent. Pediatr Infect Dis J (2007) 0.82
UPEC hemolysin: more than just for making holes. Cell Host Microbe (2012) 0.81
Quantitative assessment of human neutrophil migration across a cultured bladder epithelium. J Vis Exp (2013) 0.80
Scurvy revealed by difficulty walking: three cases in young children. J Clin Rheumatol (2014) 0.80
Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide). ACS Nano (2015) 0.78
Oseltamivir dosing in premature infants. J Infect Dis (2012) 0.75
Vitamin D sufficiency and Staphylococcus aureus infection in children. Pediatr Infect Dis J (2015) 0.75
Bacterial meningitis in children. Pediatr Case Rev (2002) 0.75